No Data
Healthcare August Recap: Moderna Jumps 156% as Biotech Shines; DaVita Sinks
Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts
Here's How Much $100 Invested In Vertex Pharmaceuticals 20 Years Ago Would Be Worth Today
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 5.61% on an annualized basis producing an average annual return of 14.84%. Currently, Vertex
Today's Bullish Patterns & Technical Sentiment | Published on 09/04: VSNT, ADM, SUNC and More
Top picks Versant Media fell 1.35% yesterday. Check out ADM, SUNC and More.
Published on 09/04: VRTX Shows Bullish Continuation Triangle as Vertex Completes Crinetics Acquisition and Expands Executive Team
Vertex Pharmaceuticals climbed 0.22% yesterday, completing acquisition of Crinetics Pharmaceuticals and expanding executive team
Today's Bullish Patterns & Technical Sentiment | Published on 09/03: VSNT, ADM, SUNC and More
Top picks Versant Media climbed 3.03% yesterday. Check out ADM, SUNC and More.